Author/Creator: Spinelli, Tulla - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Spinelli, Tulla

1. Drug–drug interaction profile of components of a fixed combination of netupitant and palonosetron: Review of clinical data. (June 2016)

Authors:: Natale, James J; Spinelli, Tulla; Calcagnile, Selma; Lanzarotti, Corinna; Rossi, Giorgia; Cox, David; Kashef, Kimia
Journal:: Journal of oncology pharmacy practice
Issue:: Volume 22:Number 3(2016:Sep.)
Page Start:: 485
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Netupitant PET imaging and ADME studies in humans. (8th November 2013)

Authors:: Spinelli, Tulla; Calcagnile, Selma; Giuliano, Claudio; Rossi, Giorgia; Lanzarotti, Corinna; Mair, Stuart; Stevens, Lloyd; Nisbet, Ian
Journal:: Journal of clinical pharmacology
Issue:: Volume 54:Number 1(2014:Jan.)
Page Start:: 97
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Oral versus intravenous palonosetron in Chinese cancer patients receiving moderately emetogenic chemotherapy: A non‐inferiority phase III trial. (21st June 2020)

Authors:: Cui, Jiuwei; Zhang, Qingyuan; Zhang, Hongyu; Spinelli, Tulla; Nicolas, Pierre; Li, Wei
Journal:: European journal of cancer care
Issue:: Volume 29:Number 4(2020)
Page Start:: n/a
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Palonosetron compared with ondansetron in pediatric cancer patients: multicycle analysis of a randomized Phase III study. (August 2017)

Authors:: Kovács, Gábor; Wachtel, Antonio; Basharova, Elena; Spinelli, Tulla; Nicolas, Pierre; Kabickova, Edita
Journal:: Future oncology
Issue:: Volume 13:Number 19(2017)
Page Start:: 1685
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Palonosetron versus ondansetron for prevention of chemotherapy-induced nausea and vomiting in paediatric patients with cancer receiving moderately or highly emetogenic chemotherapy: a randomised, phase 3, double-blind, double-dummy, non-inferiority study. Issue 3 (March 2016)

Authors:: Kovács, Gábor; Wachtel, Antonio E; Basharova, Elena V; Spinelli, Tulla; Nicolas, Pierre; Kabickova, Edita
Journal:: Lancet oncology
Issue:: Volume 17:Issue 3(2016:Mar.)
Page Start:: 332
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗